An orthogonal array distributes selected factor levels across a reduced set of experimental combinations so that comparisons remain balanced. Each factor can therefore be evaluated without being strongly entangled with the patterns assigned to other factors. This structure reduces experimental burden while helping researchers distinguish the effects of individual conditions with minimal confounding.
Factor levels define the specific conditions compared for each variable, such as alternative assay conditions, formulation settings, treatment parameters, or diagnostic workflow choices. Careful selection determines which possibilities the experiment can evaluate. Including relevant levels allows researchers to identify influential variables and prioritize conditions for later optimization or confirmatory testing.
Minimal confounding makes it easier to associate an observed change in the outcome with the factor being evaluated rather than with an uneven distribution of other conditions. This improves the interpretability of screening results and supports more defensible prioritization. In medical method development, that distinction helps narrow the variables requiring closer investigation.
The design provides a structured way to screen several factors at once rather than examining each variable in isolation. By comparing selected combinations through an orthogonal array, researchers can identify which variables appear most influential within the tested conditions. The resulting priorities guide subsequent optimization and help focus resources on the most promising settings.
Researchers first identify the factors relevant to the medical method and specify meaningful levels for each one. They then assign those conditions to an appropriate orthogonal array, conduct the reduced set of experiments, and compare the resulting outcomes across factor levels. Finally, they prioritize influential variables or settings for further optimization and confirmatory testing.
Applications include optimizing assay conditions, formulation variables, treatment parameters, and diagnostic workflows. In each case, the method helps examine several controllable conditions efficiently before a more focused evaluation. Its value is greatest when many variables require initial screening and the development process needs a systematic basis for selecting conditions to carry forward.
Orthogonal Test Design supports an early screening and prioritization stage rather than replacing confirmatory testing. Its reduced experiment set helps identify influential variables and promising condition combinations, which can then be examined more rigorously. This staged approach reduces unnecessary testing during initial development while preserving a pathway toward confirmation of selected medical methods or settings.